LIFE Competitors

Summary

LIFE Old competes with Mereo BioPharma, Terns Pharmaceuticals, PDS Biotechnology, Inozyme Pharma, and Hookipa Pharma; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing LIFE Old competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of LIFE Old to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of LIFE Old competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.00	0.00	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.00	0.00

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as LIFE Old. Your research has to be compared to or analyzed against LIFE Old's peers to derive any actionable benefits. When done correctly, LIFE Old's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in LIFE Old.

LIFE Old Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between LIFE Old and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of LIFE and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of LIFE Old does not affect the price movement of the other competitor.

	MREO	TERN	PDSB	INZY	HOOK	XFOR	DAWN	ABOS	AMLX
MREO		0.95	0.82	0.9	0.73	0.89	0.77	0.9	0.44	MREO
TERN	0.95		0.86	0.92	0.8	0.9	0.82	0.94	0.41	TERN
PDSB	0.82	0.86		0.78	0.73	0.87	0.75	0.86	0.44	PDSB
INZY	0.9	0.92	0.78		0.56	0.82	0.6	0.84	0.53	INZY
HOOK	0.73	0.8	0.73	0.56		0.8	0.95	0.83	0.03	HOOK
XFOR	0.89	0.9	0.87	0.82	0.8		0.84	0.85	0.3	XFOR
DAWN	0.77	0.82	0.75	0.6	0.95	0.84		0.83	0.1	DAWN
ABOS	0.9	0.94	0.86	0.84	0.83	0.85	0.83		0.37	ABOS
AMLX	0.44	0.41	0.44	0.53	0.03	0.3	0.1	0.37		AMLX
	MREO	TERN	PDSB	INZY	HOOK	XFOR	DAWN	ABOS	AMLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between LIFE Stock performing well and LIFE Old Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze LIFE Old's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
MREO	2.74	(0.46)	(0.55)	6.16	(6.13)	20.77
TERN	2.96	(0.93)	(0.88)	4.94	(6.75)	19.13
PDSB	4.37	(0.19)	(0.24)	9.21	(9.22)	33.91
INZY	4.08	(1.48)	(0.79)	6.82	(9.17)	36.29
HOOK	3.41	(0.70)	7.85	6.37	(7.50)	32.80
XFOR	6.16	(0.81)	(0.64)	8.11	(13.33)	68.45
DAWN	2.88	(0.56)	(0.58)	6.36	(6.67)	22.86
ABOS	3.05	(0.52)	(0.42)	6.57	(5.85)	19.77
AMLX	3.59	0.04	(0.03)	7.20	(9.09)	21.45

Unable to evaluate fundamental data of [MREO, TERN, PDSB, INZY, HOOK, XFOR, DAWN, ABOS, AMLX] at this time. Please try again later

All Fundamental Data

LIFE Old Competitive Analysis

The better you understand LIFE Old competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, LIFE Old's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across LIFE Old's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	MREO	TERN	PDSB	INZY	HOOK	XFOR	DAWN	ABOS	AMLX
	4.56 2.30 Mereo	6.41 2.92 Terns	0.80 1.26 PDS	7.07 0.92 Inozyme	1.67 1.18 Hookipa	7.41 0.25 XFOR	1.47 8.07 Day	3.25 1.19 Acumen	5.43 3.66 Amylyx
Market Volatility (90 Days Market Risk)	Unstable	Slightly risky	Very risky	Unstable	Unstable	Out of control	Somewhat reliable	Unstable	Unstable
Market Performance (90 Days Performance)	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	About Average	Average	High	Very High	Below Average	Below Average	Average	Quite High	Low
Current Valuation (Equity Enterprise Value)	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Buy	Strong Buy	Strong Buy	Strong Buy	Buy
Trade Advice (90 Days Macroaxis Advice)	Sell	Strong Sell	Strong Sell	Strong Sell	Sell	Strong Sell	Strong Sell	Sell	Sell
Current Ratio	7.92	23.59	12.34	14.54	5.48	2.39	31.45	37.21	7.96
Net Asset	76.39 M	363.93 M	45.36 B	123.18 M	82.55 M	146.45 M	582.79 M	310.12 M	193.63 M
Profit Margin	N/A	N/A	N/A	N/A	-0.99	N/A	-0.73	N/A	N/A
EBITDA	(47.36 M)	(101.87 M)	(36.32 B)	(104.03 M)	(51.45 M)	(36.4 M)	(217.27 M)	(51.61 M)	(290.98 M)
Operating Margin	-37.9	N/A	N/A	N/A	-12.68	-24.91	-2.24	N/A	61.13
Current Valuation	302.33 M	(101.91 M)	36.32 M	(7.1 M)	(24.58 M)	19.44 M	288.81 M	(71.33 M)	149.77 M
Price To Book	6.0	0.74	2.96	1.02	0.28	1.96	1.63	0.39	1.97
Retained Earnings	(462.88 M)	(421.48 M)	(182.11 B)	(387.95 M)	(412.76 M)	(515.36 M)	(554.08 M)	(222.8 M)	(606.69 M)
Current Asset	94 K	N/A	39.11 M	N/A	26.61 M	N/A	N/A	N/A	N/A
Beta	0.97	-0.31	1.67	1.31	0.7	0.39	-1.39	0.024	-0.51
Number Of Employees	N/A	59	25	67	82	143	181	51	123
Equity Positions Weight	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	50.03
Shares Outstanding	153.85 M	87.3 M	44.59 M	64.24 M	9.66 M	173.66 M	101.36 M	60.08 M	88.6 M
Cash Flow From Operations	(32.83 M)	(70.02 M)	(35.03 B)	(91.91 M)	(76.98 M)	(130.9 M)	(78.11 M)	(43.06 M)	(167.65 M)
Total Debt	894 K	1.35 M	12.62 B	15.41 M	875 K	2.66 M	2.6 M	28.49 M	1.98 M
Return On Equity	-0.48	-0.3	-1.74	-1.03	-0.62	-1.02	-0.22	-0.33	-1.01
Return On Asset	-0.24	-0.2	-0.45	-0.4	-0.23	-0.6	-0.28	-0.21	-0.51
Number Of Shares Shorted	6.03 M	5.95 M	3.86 M	3.99 M	70.64 K	8.64 M	17.02 M	1.78 M	3.75 M
Book Value Per Share	0.51	3.97	0.6	0.9	4.08	0.13	4.97	3.62	2.4
Current Liabilities	729 K	N/A	4.54 M	N/A	25.01 M	N/A	N/A	N/A	N/A
Total Asset	76.39 M	363.93 M	45.36 B	123.18 M	82.55 M	146.45 M	582.79 M	310.12 M	193.63 M
Debt To Equity	0.19	0.01	0.007	0.02	0.052	1.28	0.002	N/A	0.036
Short Ratio	6.58	5.57	2.83	6.93	1.03	6.19	11.31	8.97	4.64
Target Price	7.22	19.06	8.13	13.5	4.5	2.67	31.13	9.2	8.0
Shares Owned By Institutions	65.66	99.75	9.57	92.63	58.65	58.14	94.59	76.57	65.66
Market Capitalization	630.8 M	254.91 M	56.18 M	59.11 M	14.23 M	43.42 M	817.93 M	71.49 M	324.29 M
Price To Earning	6.73	N/A	24.7	N/A	12.06	N/A	3.88	N/A	N/A
Price To Earnings To Growth	N/A	N/A	-0.05	-0.06	-0.19	N/A	N/A	-0.23	-0.15
Price To Sales	598.13	302.64	N/A	N/A	0.32	16.98	6.24	538.78	3.71
Net Income	(43.25 M)	(88.85 M)	(37.61 B)	(102.02 M)	(43.5 M)	(37.45 M)	(95.5 M)	(52.37 M)	(301.74 M)
Earnings Per Share	-0.25	-1.12	-1.03	-1.62	-3.47	-0.19	-1.02	-1.71	-4.43
Shares Owned By Insiders	1.02	0.25	3.1	1.19	2.0	1.24	16.96	11.23	11.69
Revenue	N/A	N/A	N/A	N/A	43.95 M	2.56 M	131.16 M	N/A	87.37 M
Working Capital	60.91 M	346.46 M	45.43 M	86.78 M	56.01 M	79.3 M	488.88 M	233.64 M	161.03 M
Cash And Equivalents	94.3 M	139.81 M	52.98 M	151.48 M	117.92 M	47.38 M	394.86 M	189.91 M	206.68 M
Cash Per Share	0.81	5.51	1.86	3.77	2.16	0.69	5.38	4.69	3.53
Gross Profit	936 K	1000 K	N/A	N/A	(23.19 M)	1.76 M	125.88 M	(43.56 M)	(141.35 M)
Day Typical Price	2.35	2.98	1.24	0.96	1.2	0.26	8.1	1.2	3.69
Accumulation Distribution	0.0806	0.0675	0.0853	0.11	0.0565	0.11	0.0434	0.08	0.0779
Market Facilitation Index	0.2	0.21	0.11	0.11	0.07	0.03	0.36	0.1	0.3
Daily Balance Of Power	(0.55)	(0.95)	0.0909	(0.64)	(0.29)	(0.67)	(0.33)	(0.40)	(0.70)
Period Momentum Indicator	(0.11)	(0.20)	0.01	(0.07)	(0.02)	(0.02)	(0.12)	(0.04)	(0.21)
Rate Of Daily Change	0.95	0.94	1.01	0.93	0.98	0.93	0.99	0.97	0.95
Day Median Price	2.38	3.01	1.23	0.98	1.21	0.27	8.11	1.2	3.7
Price Action Indicator	(0.14)	(0.19)	0.03	(0.09)	(0.04)	(0.03)	(0.10)	(0.03)	(0.14)
Relative Strength Index	37.85	34.91	44.08	30.01	37.04	33.42	36.72	38.76	53.73
Coefficient Of Variation	(766.18)	(382.79)	(2,643)	(374.65)	(719.50)	(1,198)	(672.42)	(659.71)	(9,432)
Mean Deviation	2.74	2.96	4.37	4.08	3.41	6.16	2.88	3.05	3.59
Jensen Alpha	(0.46)	(0.93)	(0.19)	(1.48)	(0.70)	(0.81)	(0.56)	(0.52)	0.0411
Total Risk Alpha	(0.27)	(0.75)	0.1416	(1.22)	(0.39)	(0.23)	(0.36)	(0.36)	0.2292
Standard Deviation	3.81	3.75	6.09	5.93	4.96	10.49	4.11	3.9	4.59
Kurtosis	1.5	0.4809	2.58	5.97	3.07	13.81	3.9	0.1534	(0.09)
Potential Upside	6.16	4.94	9.21	6.82	6.37	8.11	6.36	6.57	7.2
Treynor Ratio	(0.55)	(0.88)	(0.24)	(0.79)	7.85	(0.64)	(0.58)	(0.42)	(0.03)
Maximum Drawdown	20.77	19.13	33.91	36.29	32.8	68.45	22.86	19.77	21.45
Variance	14.52	14.08	37.13	35.14	24.63	110.0	16.86	15.23	21.07
Market Risk Adjusted Performance	(0.54)	(0.87)	(0.23)	(0.78)	7.86	(0.63)	(0.57)	(0.41)	(0.02)
Risk Adjusted Performance	(0.10)	(0.22)	(0.02)	(0.22)	(0.11)	(0.06)	(0.12)	(0.12)	(0.001)
Skewness	0.7001	0.3622	1.03	(1.28)	0.3848	3.0	(0.32)	0.3975	(0.19)
Information Ratio	(0.12)	(0.25)	(0.03)	(0.26)	(0.13)	(0.08)	(0.14)	(0.14)	(0)
Value At Risk	(6.13)	(6.75)	(9.22)	(9.17)	(7.50)	(13.33)	(6.67)	(5.85)	(9.09)

LIFE Old Competition Performance Charts

Five steps to successful analysis of LIFE Old Competition

LIFE Old's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by LIFE Old in relation to its competition. LIFE Old's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of LIFE Old in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact LIFE Old's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to LIFE Old, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your LIFE Old position

In addition to having LIFE Old in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banks Thematic Idea Now

Banks

Large and small money and credit banks and credit services. The Banks theme has 38 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.

View All Next

Launch

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in LIFE Stock

If you are still planning to invest in LIFE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LIFE Old's history and understand the potential risks before investing.

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC